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We present the case of a 28-year-old patient successfully implanted with a subcutaneous implantable cardioverter-defibril-
lator (S-ICD) in secondary prevention of sudden cardiac death. The patient was resuscitated from out-of-hospital cardiac 
arrest due to ventricular fibrillation (VF). This was complicated by pneumothorax and respiratory failure that required 
mechanical ventilation for 5 days. After 2 weeks on the intensive care unit, the patient was transferred to the Cardiology 
Department. A subsequent medical evaluation revealed no structural heart abnormalities, nor other overt cardiovascular 
dysfunctions. However, during an invasive electrophysiological study, VF was induced with programmed right ventricular 
stimulation (Fig. 1). Therefore, the patient was implanted with an ICD. One week after this procedure, he presented 
symptoms of fever, shivers and chest pain. A fulminant endocarditis and right ventricle perforation was diagnosed. Subse-
quently, an adequate intravenous antibiotic treatment was introduced and the ICD system was explanted. Nevertheless, 
the important destruction of the tricuspid valve was revealed in echocardiography, and cardiothoracic surgery with artificial 
tricuspid valve replacement (Medtronic 29 mm) was performed. The surgery was complicated by intermittent complete 
atrio-ventricular block, thus the epicardial lead was implanted to the left ventricle and connected to the pacemaker placed 
in the right subclavian region. After 3 weeks of in-hospital recovery, the patient was consulted by an international board 
of arrhythmology specialists in order to establish the possibility of S-ICD implantation. The electrocardiography screening 
to check S-ICD arrhythmia discriminators matching with sensed cardiac signals was completed successfully, as well on the 
intrinsic rhythm as during pacing. Eventually, the patient 
was referred to S-ICD implantation. The procedure was 
performed on oral anticoagulation with acenocoumarol 
(INR on the day of procedure was 2.1), in volatile and 
maintenance anaesthesia by a joint team of cardiologist 
and cardiothoracic surgeon. The S-ICD was positioned 
in the left lateral region between the 5th and 7th inter-
costal spaces. The subcutaneous defibrillation lead was 
implanted atypically — in parasternal instead of medial 
line. The reason for atypical positioning of the lead was 
to avoid collision with the epicardial lead that had been 
previously implanted in the substernal region and to avert 
complications in case of future medial resternotomy. The 
position of the device and the lead is presented in Fig-
ure 2. Considering the high thromboembolic risk, testing 
of the defibrillator was successfully performed after tran-
soesophageal echocardiography on the 4th day after the 
implantation. The post-procedure course was uneventful. 
We present the first Polish experience of implantation of 
a S-ICD system. This modern therapy is an option for those 
patients who cannot have a standard ICD implanted for 
any reason, e.g. vascular abnormalities or intravascular 
infection. This procedure, although it is still not routinely 
reimbursed by the public health system, has become 
a new treatment option for Polish patients. 
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Figure 2. Chest X-ray of the patient with pacemaker connected 
to epicardial lead, artificial tricuspid valve and subcutaneous 
implantable cardioverter-defibrillator
Figure 1. Ventricular fibrillation induced during invasive 
electro physiological study
